Mar 21, 2019 / 03:00PM GMT
Operator
Good afternoon, ladies and gentlemen, and thank you for standing by, and welcome to today's Zealand Pharma R&D and Business Update Conference Call. (Operator Instructions) I must advise you that this conference is being recorded today, Thursday, the 21st of March 2019.
I would now like to hand the conference over to your speaker today, Adam Steensberg. Please go ahead, sir.
Adam Steensberg - Zealand Pharma A/S-Interim CEO - Executive VP and Chief Medical & Development Officer
Thank you, Annette, and welcome, everyone. It's great to have you join this exciting R&D update. Joining me on today's call is Andrew Parker, our Chief Science Officer.
Page 2 outlines what we will cover during today's call. We have spent significant time talking about our late stage program, but today is a great opportunity to discuss our research and preclinical programs. I will start by providing highlights from our recently signed collaboration with Alexion Pharmaceuticals, with whom we are thrilled to be
Zealand Pharma A/S - Special Call Transcript
Mar 21, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers